Generic substitution: a need for clarification.
作者信息
Peterson Gregory M
出版信息
Br J Clin Pharmacol. 2011 Jun;71(6):966-7; author reply 968. doi: 10.1111/j.1365-2125.2010.03872.x.
Abstract
摘要
相似文献
1
Generic substitution: a need for clarification.通用替换：需要澄清。
Br J Clin Pharmacol. 2011 Jun;71(6):966-7; author reply 968. doi: 10.1111/j.1365-2125.2010.03872.x.
2
Generic and therapeutic substitutions in the UK: are they a good thing?英国的非专利药和通用名药替代：这是好事吗？
Br J Clin Pharmacol. 2010 Sep;70(3):335-41. doi: 10.1111/j.1365-2125.2010.03718.x.
3
The Effect of Medicare Part D on Pharmaceutical Prices and Utilization.医疗保险处方药计划（Medicare Part D）对药品价格和使用的影响。
Am Econ Rev. 2010 Mar;100(1):590-607. doi: 10.1257/aer.100.1.590.
4
Does generic substitution always make sense?
J Med Econ. 2008;11(3):547-53. doi: 10.3111/13696990802371075.
5
The effects of copayments and generic substitution on the use and costs of prescription drugs.共付额和通用名药物替代对处方药使用及成本的影响。
Inquiry. 1993 Summer;30(2):189-98.
6
Generic prescribing and substitution: the big issues.
Br J Community Nurs. 2010 May;15(5):248-9. doi: 10.12968/bjcn.2010.15.5.47951.
7
Summaries for Patients. Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications.
Ann Intern Med. 2016 Jan 5;164(1). doi: 10.7326/P16-9002. Epub 2015 Nov 24.
8
Generic psychotropic medications: issues of cost-effectiveness and patient benefit.通用精神药物：成本效益与患者获益问题
South Med J. 2011 Oct;104(10):711-4. doi: 10.1097/SMJ.0b013e31822cf1ea.
9
A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance.全国性研究澳大利亚社区药剂师和患者对通用药品替代实践的接受程度。
Health Policy. 2011 Feb;99(2):139-48. doi: 10.1016/j.healthpol.2010.08.002. Epub 2010 Aug 21.
10
Generic antiepileptic drugs and associated medical resource utilization in the United States.美国的通用抗癫痫药物和相关医疗资源利用情况。
Neurology. 2010 May 18;74(20):1566-74. doi: 10.1212/WNL.0b013e3181df091b. Epub 2010 Apr 14.
引用本文的文献
1
Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications.生物治疗药物的免疫原性：原因及与翻译后修饰的关联
J Immunol Res. 2016;2016:1298473. doi: 10.1155/2016/1298473. Epub 2016 Jun 29.
2
The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review.仿制药替代对健康和经济结果的影响：一项系统评价
Appl Health Econ Health Policy. 2015 Aug;13 Suppl 1(Suppl 1):S21-33. doi: 10.1007/s40258-014-0147-0.
3
Interchangeability, immunogenicity and biosimilars.互换性、免疫原性与生物类似药。
Nat Biotechnol. 2012 Dec;30(12):1186-90. doi: 10.1038/nbt.2438.
本文引用的文献
1
Generic and therapeutic substitutions in the UK: are they a good thing?英国的非专利药和通用名药替代：这是好事吗？
Br J Clin Pharmacol. 2010 Sep;70(3):335-41. doi: 10.1111/j.1365-2125.2010.03718.x.
2
Understanding therapeutic equivalence in epilepsy.理解癫痫治疗等效性。
CNS Spectr. 2010 Feb;15(2):112-23. doi: 10.1017/s1092852900027358.
3
Generic medicines literacy - minimising the potential for patient confusion.仿制药知识普及——降低患者困惑的可能性。
Med J Aust. 2010 Apr 5;192(7):368-9. doi: 10.5694/j.1326-5377.2010.tb03555.x.
4
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.比较仿制药和创新药：对美国食品药品监督管理局12年生物等效性数据的综述
Ann Pharmacother. 2009 Oct;43(10):1583-97. doi: 10.1345/aph.1M141. Epub 2009 Sep 23.
5
From the Food and Drug Administration.来自美国食品药品监督管理局。
JAMA. 1999 Dec 1;282(21):1995.
Zotero 插件